Johnson & Johnson vs Eli Lilly and Company — Stock Comparison
Johnson & Johnson (JNJ) and Eli Lilly and Company (LLY) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Eli Lilly and Company scores ahead of Johnson & Johnson on Q·Score (8 vs 7.1 out of 10), led by Growth (9.7 vs 5.1) and Sentiment (7.7 vs 6.9). Johnson & Johnson scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analyst price targets imply similar upside for both: +5.4% for JNJ and +6.1% for LLY.
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Earnings growing 170% year-over-year on 56% revenue growth.
Analyst Consensus
Fundamentals
Frequently Asked Questions
JNJ vs LLY: which stock scores better overall?
Based on Q·Score, Eli Lilly and Company (LLY) scores 8/10 versus Johnson & Johnson (JNJ) at 7.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: JNJ or LLY?
Eli Lilly and Company (LLY) scores higher on Growth (9.7/10 vs 5.1/10). Johnson & Johnson reports revenue growth (9.9% YoY) while Eli Lilly and Company reports (55.5% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is JNJ or LLY more attractively valued?
Johnson & Johnson (JNJ) scores higher on Valuation (7/10 vs 6.3/10). JNJ trades at 18.9× P/E versus LLY at 25.8×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about JNJ vs LLY?
There are 23 analysts covering JNJ with a consensus price target of $252.87, and 29 analysts covering LLY with a consensus target of $1215.79. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: JNJ or LLY?
Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 9/10). Net profit margin: JNJ at 21.8%, LLY at 35.0%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: JNJ or LLY?
Eli Lilly and Company (LLY) scores higher on Financial Health (7/10 vs 6.5/10). Market beta: JNJ at 0.26, LLY at 0.52. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of JNJ and LLY?
Johnson & Johnson (JNJ) has a market capitalisation of $577.6B, while Eli Lilly and Company (LLY) has a market cap of $1.02T. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do JNJ or LLY pay dividends?
JNJ pays a dividend yield of 2.25%, while LLY pays a dividend yield of 0.60%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →